BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 705561)

  • 1. [Factor XII (Hageman factor) purification and anti-Hageman antibodies production (author's transl)].
    EspaƱa F; Aznar J
    Sangre (Barc); 1978; 23(4):393-401. PubMed ID: 705561
    [No Abstract]   [Full Text] [Related]  

  • 2. A rapid purification with high recovery of factor XII (Hageman factor) on immunoaffinity column: application to an abnormal clotting factor XII (factor XIITORONTO).
    Takahashi I; Saito H
    J Biochem; 1988 Apr; 103(4):641-3. PubMed ID: 3139646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine prekallikrein activator with functional activity as Hageman factor.
    Komiya M; Nagasawa S; Suzuki T
    J Biochem; 1972 Nov; 72(5):1205-18. PubMed ID: 4675207
    [No Abstract]   [Full Text] [Related]  

  • 4. Activated human Hageman factor (XII).
    Speer RJ; Ridgway H; Hill JM
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):1-11. PubMed ID: 16955961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XII: Hageman factor.
    Pixley RA; Colman RW
    Methods Enzymol; 1993; 222():51-65. PubMed ID: 8412813
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoquantitation of Hageman factor in urine and plasma of children with nephrotic syndrome.
    Hruby MA; Honig GR; Shapira E
    J Lab Clin Med; 1980 Sep; 96(3):501-10. PubMed ID: 6772722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of a monoclonal antibody against factor XII (Hageman factor); enzyme-linked immunosorbent assay (ELISA) for factor XII antigen].
    Sugihara T; Saito H
    Nihon Ketsueki Gakkai Zasshi; 1987 May; 50(3):691-5. PubMed ID: 3425183
    [No Abstract]   [Full Text] [Related]  

  • 8. [Isolation, purification, and properties of factor XII and its active fragment (beta-XIIa)].
    Blokhina TB; Neshkova EA; Iarovaia GA
    Vopr Med Khim; 2002; 48(6):603-10. PubMed ID: 12698561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma factor XII (Hageman factor) in disease states (author's transl)].
    Ichinose A; Maruyama I; Imaguma M; Sonoda T; Igata A
    Rinsho Ketsueki; 1981 Aug; 22(8):1232-6. PubMed ID: 7328776
    [No Abstract]   [Full Text] [Related]  

  • 10. [Isolation and some properties of Hageman factor and its active fragment from human blood].
    Krizhevskaia IuV; Iarovaia GA; Dotsenko VL; Khvatov VB
    Biokhimiia; 1981 Aug; 46(8):1510-8. PubMed ID: 7272366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of Hageman factor (factor XII) on columns of popcorn-agarose.
    Ratnoff OD; Everson B; Donaldson VH; Mitchell BH
    Blood; 1986 Jun; 67(6):1550-3. PubMed ID: 3708154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the activation of Hageman factor (factor XII) by soluble human placental collagens types III, IV, and V.
    Koenig JM; Chahine A; Ratnoff OD
    J Lab Clin Med; 1991 Jun; 117(6):523-7. PubMed ID: 1646270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of expression of monocyte interleukin-1 by inhibitors of Hageman factor (factor XII).
    Ratnoff OD; Voytus JA; Toossi Z
    J Lab Clin Med; 1995 Feb; 125(2):247-50. PubMed ID: 7844472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of Hageman factor and immune complexes.
    Cochrane CG; Wuepper KD; Aiken BS; Revak SD; Spiegelberg HL
    J Clin Invest; 1972 Oct; 51(10):2736-45. PubMed ID: 5056666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physico-chemical and immunological properties of bovine Hageman factor.
    Grammens GL; Prasad AS; Mammen EF; Barnhart MI
    Thromb Diath Haemorrh; 1971 Jun; 25(3):405-24. PubMed ID: 5105490
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification of factor XII (Hageman factor) from human plasma.
    Chan JY; Movat HZ
    Thromb Res; 1976 Mar; 8(3):337-49. PubMed ID: 817410
    [No Abstract]   [Full Text] [Related]  

  • 17. The purification of activated Hageman factor from human granulocytes.
    Prokopowicz J; Wolosowicz N; Szmitkowski M
    Thromb Diath Haemorrh; 1972 Apr; 27(2):228-33. PubMed ID: 5049612
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.
    Foster CB; Flanigan TP; DeStigter KK; Blanton R; Dumenco LL; Gallagher C; Ratnoff OD
    J Lab Clin Med; 1992 Nov; 120(5):735-9. PubMed ID: 1431502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of a murine monoclonal antibody against a heavy chain of Hageman factor (factor XII).
    Saito H; Ishihara T; Suzuki H; Watanabe T
    Blood; 1985 May; 65(5):1263-8. PubMed ID: 3922451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The secondary structure of human Hageman factor (factor XII) and its alteration by activating agents.
    McMillin CR; Saito H; Ratnoff OD; Walton AG
    J Clin Invest; 1974 Dec; 54(6):1312-22. PubMed ID: 4373492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.